Week commencing 18 June saw me attending a research retreat at the University of Saskatchewan, Canada, building on successful collaboration with Canadian colleagues (via 2 CIHR development grants) established around 5 years ago my colleague Professor Debra Morgan is now leading a large programme grant application to the Canadian Institutes of Health Research (CIHR) which would allow for comparative work to be conducted in Dorset and Canada around community based dementia services. As well as academic meetings discussing the content, focus and budgetary implications of the programme of work there was a one day ‘Stakeholder’ event where decision makers debated the merits of the four strands of the programme of proposed work. This was a fantastic example of public engagement in writing a programme grant and the opening presentation I gave about the UK dementia strategies and implementation plans were very well received. It is always good to have synergy between work going on in different places and to learn from one another. Canadian colleagues were very complimentary about the policy level work that has been established within the UK, but some of the practical initiatives occuring in rural Canada are very much at the forefront of quality dementia care provision. Here’s hoping we secure the grant award!
Canada-UK Artificial Intelligence Initiative: building competitive and resilient economies and societies through responsible AI










Beyond Academia: Exploring Career Options for Early Career Researchers – Online Workshop
UKCGE Recognised Research Supervision Programme: Deadline Approaching
SPROUT: From Sustainable Research to Sustainable Research Lives
BRIAN upgrade and new look
Seeing the fruits of your labour in Bangladesh
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease